Shehnaaz Suliman
Chief Executive Officer and Board Member at ReCode Therapeutics - Menlo Park, CA, US
Shehnaaz Suliman's Colleagues at ReCode Therapeutics
Shehnaaz Suliman's Contact Details
408-585-1700
San Mateo,California,United States
ReCode Therapeutics
Shehnaaz Suliman's Company Details
ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases. The Company's diverse pipeline includes lead programs for cystic fibrosis (CF) caused by nonsense mutations, and primary ciliary dyskinesia (PCD). ReCode has developed a non-viral delivery therapeutic platform that enables it to precisely deliver its medicines safely and effectively. The Company is leveraging its lipid nanoparticle and nucleic acid technologies across multiple modalities, including mRNA-mediated replacement therapies, first-in-class tRNA NanoCorrectors for diseases caused by nonsense mutations, and gene editing. For more information, visit www.recodetx.com or contact us at info@recodetx.com.